Institutional investors purchased a net $144.1 million shares of ABBV during the quarter ended September 2014 and now own 80.59% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 24.0 Million shares of AbbVie
OZ MANAGEMENT LP Bought 15.3 Million shares of AbbVie
PAULSON & CO., INC. Bought 13.0 Million shares of AbbVie